Eiger is a clinical-stage biopharmaceutical company committed to developing and commercializing novel products for the treatment of rare diseases. Eiger has built a diverse, late-stage portfolio of well-characterized product candidates with the potential to address diseases for which the unmet medical need is high, a novel biology for treatment has been identified, and for which an effective therapy is urgently needed. The Eiger management team has extensive experience in the clinical development a... More >>
|Data as of Dec 11, 2019 8:51 PM EST
Recent NewsMore >>
Upcoming EventsMore >>
More events are coming soon.
There are currently no items available.